Therapeutic resistance in autoimmune diseases

Abstract

Get full access to this article

View all access options for this article.

References

Almeida

Faria

Vita

Vasconcelos

. Systemic sclerosis refractory disease: From the skin to the heart. Autoimmun Rev 2011; 10: 693–701.

Eddou

Helissey

Konopacki

. Syndrome d’Evans: attention aux diagnostics par excès [Evans syndrome: Be careful of over-diagnosis] [in French]. Rev Med Interne 2012; 33: 155–158.

Arnaud

Zahr

Costedoat-Chalumeau

Amoura

. The importance of assessing medication exposure to the definition of refractory disease in systemic lupus erythematosus. Autoimmun Rev 2011; 10: 674–678.

Ginzler

Dooley

Aranow

. Mycophenolate mofetil or intravenous cyclophosphamide for lupus nephritis. N Engl J Med 2005; 353: 2219–2228.

Grootscholten

Ligtenberg

Hagen

. Azathioprine/methylprednisolone versus cyclophosphamide in proliferative lupus nephritis. A randomized controlled trial. Kidney Int 2006; 70: 732–742.

Singh

Solomon

Dougados

. Development of classification and response criteria for rheumatic diseases. Arthritis Rheum 2006; 55: 348–352.

Gordon

Jayne

Pusey

. European consensus statement on the terminology used in the management of lupus glomerulonephritis. Lupus 2009; 18: 257–263.

Chen

Korbet

Katz

. Value of a complete or partial remission in severe lupus nephritis. Clin J Am Soc Nephrol 2008; 3: 46–53.

Tak

. A personalized medicine approach to biologic treatment of rheumatoid arthritis: A preliminary treatment algorithm. Rheumatology 2012; 51: 600–609.

10.

Lau

Manes

Celermajer

Galiè

. Early detection of pulmonary vascular disease in pulmonary arterial hypertension: Time to move forward. Eur Heart J 2011; 32: 2489–2498.

11.

Farge

Labopin

Tyndall

. Autologous hematopoietic stem cell transplantation for autoimmune diseases: An observational study on 12 years’ experience from the European Group for Blood and Marrow Transplantation Working Party on Autoimmune Diseases. Haematologica 2010; 95: 284–292.